Katharina Stratmann1, Katarzyna Czerwinska2, Natalie Filmann3, Wolfgang Tacke4, Christoph Weber4, Herbert Bock5, Irina Blumenstein2. 1. Department of Medicine I, J.W. Goethe University Frankfurt, Frankfurt, Germany. katharina.stratmann@kgu.de. 2. Department of Medicine I, J.W. Goethe University Frankfurt, Frankfurt, Germany. 3. Institute of Biostatistics and Math Modeling, J.W. Goethe University Hospital Frankfurt, Frankfurt, Germany. 4. Facharztzentrum am Taunus, Taunus, Germany. 5. Gastroenterologische Facharztpraxis, Zeil, 65, Frankfurt, Germany.
Abstract
PURPOSE: Colorectal cancer (CRC) is the second most common cancer in Germany. Around 60,000 people were diagnosed CRC in 2016 in Germany. Since 2019, screening colonoscopies are offered in Germany for men by the age of 50 and for women by the age of 55. It is recently discussed if women should also undergo a screening colonoscopy by the age of 50 and if there are any predictors for getting CRC. METHODS: Colonoscopies of 1553 symptomatic patients younger than 55 years were compared with colonoscopies of 1075 symptomatic patients older than 55 years. We analyzed if there are any significant differences between those two groups in the prevalence of CRC and its precursor lesions or between symptomatic men and women. We evaluated if there is a correlation between abdominal symptoms and the prevalence of CRC. RESULTS: In 164/1553 symptomatic patients, 194 (12.5%) polyps were detected. In total, six colorectal carcinomas (0.4%) were detected. There were no significant differences between men and women. In symptomatic patients ≥ 55 years, significantly more polyps were found (p<0.0001; 26.6% vs. 12.5%). Totally, 286 polyps (26.6%) were removed in 1075 symptomatic patients older than 55 years. Anorectal bleeding was the only abdominal symptom being a significant indicator for the prevalence of the occurrence of colon and rectum cancer in both groups (p=0.03, OR=2.73 95%-CI [1.11;6.70]), but with only low sensitivity (44%). CONCLUSION: Due to no significant differences in men and women, we recommend screening colonoscopies also for women by the age of 50.
PURPOSE:Colorectal cancer (CRC) is the second most common cancer in Germany. Around 60,000 people were diagnosed CRC in 2016 in Germany. Since 2019, screening colonoscopies are offered in Germany for men by the age of 50 and for women by the age of 55. It is recently discussed if women should also undergo a screening colonoscopy by the age of 50 and if there are any predictors for getting CRC. METHODS: Colonoscopies of 1553 symptomatic patients younger than 55 years were compared with colonoscopies of 1075 symptomatic patients older than 55 years. We analyzed if there are any significant differences between those two groups in the prevalence of CRC and its precursor lesions or between symptomatic men and women. We evaluated if there is a correlation between abdominal symptoms and the prevalence of CRC. RESULTS: In 164/1553 symptomatic patients, 194 (12.5%) polyps were detected. In total, six colorectal carcinomas (0.4%) were detected. There were no significant differences between men and women. In symptomatic patients ≥ 55 years, significantly more polyps were found (p<0.0001; 26.6% vs. 12.5%). Totally, 286 polyps (26.6%) were removed in 1075 symptomatic patients older than 55 years. Anorectal bleeding was the only abdominal symptom being a significant indicator for the prevalence of the occurrence of colon and rectum cancer in both groups (p=0.03, OR=2.73 95%-CI [1.11;6.70]), but with only low sensitivity (44%). CONCLUSION: Due to no significant differences in men and women, we recommend screening colonoscopies also for women by the age of 50.
Authors: Christian P Pox; Lutz Altenhofen; Hermann Brenner; Arno Theilmeier; Dominik Von Stillfried; Wolff Schmiegel Journal: Gastroenterology Date: 2012-03-21 Impact factor: 22.682
Authors: Bernd Bokemeyer; Herbert Bock; Dietrich Hüppe; Marc Düffelmeyer; Axel Rambow; Wolfgang Tacke; Herbert Koop Journal: Eur J Gastroenterol Hepatol Date: 2009-06 Impact factor: 2.566
Authors: Irina Blumenstein; Wolfgang Tacke; Herbert Bock; Natalie Filmann; Elena Lieber; Stefan Zeuzem; Jörg Trojan; Eva Herrmann; Oliver Schröder Journal: Eur J Gastroenterol Hepatol Date: 2013-05 Impact factor: 2.566
Authors: Thomas F Imperiale; David R Wagner; Ching Y Lin; Gregory N Larkin; James D Rogge; David F Ransohoff Journal: N Engl J Med Date: 2002-06-06 Impact factor: 91.245
Authors: Frank T Kolligs; Alexander Crispin; Axel Munte; Andreas Wagner; Ulrich Mansmann; Burkhard Göke Journal: PLoS One Date: 2011-05-24 Impact factor: 3.240